ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04380	Osteoclast differentiation	25/160	134/7206	7.94645641823e-17
ko04060	Cytokine-cytokine receptor interaction	25/160	191/7206	4.11696302898e-13
ko05161	Hepatitis B	23/160	173/7206	2.81148439497e-12
ko04621	NOD-like receptor signaling pathway	22/160	157/7206	2.96831644725e-12
ko05164	Influenza A	21/160	167/7206	7.95399433767e-11
ko05168	Herpes simplex infection	21/160	182/7206	4.08159284754e-10
ko05162	Measles	17/160	120/7206	8.75264910297e-10
ko04668	TNF signaling pathway	17/160	120/7206	8.75264910297e-10
ko05167	Kaposi's sarcoma-associated herpesvirus infection	21/160	191/7206	1.00600923754e-09
ko04630	Jak-STAT signaling pathway	17/160	132/7206	3.93879773821e-09
ko04620	Toll-like receptor signaling pathway	15/160	100/7206	4.04000947451e-09
ko05160	Hepatitis C	18/160	153/7206	5.84208917182e-09
ko05140	Leishmaniasis	13/160	75/7206	7.5324464875e-09
ko05145	Toxoplasmosis	16/160	126/7206	1.42838116493e-08
ko04064	NF-kappa B signaling pathway	14/160	96/7206	1.98541536348e-08
ko05321	Inflammatory bowel disease (IBD)	11/160	56/7206	2.88261992123e-08
ko04660	T cell receptor signaling pathway	15/160	124/7206	8.02994846021e-08
ko04622	RIG-I-like receptor signaling pathway	11/160	62/7206	8.77166498038e-08
ko05323	Rheumatoid arthritis	12/160	89/7206	5.14819440231e-07
ko04672	Intestinal immune network for IgA production	8/160	37/7206	1.10741862757e-06
ko04933	AGE-RAGE signaling pathway in diabetic complications	14/160	135/7206	1.49662746927e-06
ko04217	Necroptosis	16/160	178/7206	1.78976649745e-06
ko04210	Apoptosis	16/160	180/7206	2.07598780476e-06
ko05152	Tuberculosis	16/160	187/7206	3.43148475246e-06
ko04659	Th17 cell differentiation	12/160	106/7206	3.44554698706e-06
ko05144	Malaria	8/160	45/7206	5.31655949566e-06
ko05166	HTLV-I infection	20/160	292/7206	6.26768980967e-06
ko05330	Allograft rejection	6/160	24/7206	1.05437906028e-05
ko04917	Prolactin signaling pathway	10/160	87/7206	2.02238477078e-05
ko04657	IL-17 signaling pathway	10/160	87/7206	2.02238477078e-05
ko05340	Primary immunodeficiency	6/160	30/7206	4.16537178838e-05
ko04658	Th1 and Th2 cell differentiation	10/160	96/7206	4.80391388411e-05
ko04650	Natural killer cell mediated cytotoxicity	10/160	97/7206	5.25509807231e-05
ko05133	Pertussis	9/160	87/7206	0.000122165512799
ko05142	Chagas disease (American trypanosomiasis)	11/160	130/7206	0.000136657003024
ko05169	Epstein-Barr virus infection	14/160	206/7206	0.000181723484335
ko04623	Cytosolic DNA-sensing pathway	6/160	41/7206	0.000257782102752
ko04612	Antigen processing and presentation	8/160	77/7206	0.000284289312945
ko05320	Autoimmune thyroid disease	5/160	29/7206	0.000391058331857
ko04062	Chemokine signaling pathway	13/160	201/7206	0.000501177140867
ko05332	Graft-versus-host disease	4/160	18/7206	0.000561742769068
ko04662	B cell receptor signaling pathway	8/160	88/7206	0.000706660220491
ko04670	Leukocyte transendothelial migration	10/160	151/7206	0.00187769812628
ko05131	Shigellosis	7/160	82/7206	0.00219663401892
ko04145	Phagosome	10/160	162/7206	0.00314654723624
ko04931	Insulin resistance	9/160	137/7206	0.0033244359272
ko04920	Adipocytokine signaling pathway	7/160	89/7206	0.00349913666889
ko04940	Type I diabetes mellitus	4/160	32/7206	0.00518544806218
ko05310	Asthma	3/160	17/7206	0.00581076321633
ko05134	Legionellosis	6/160	74/7206	0.00582386307865
ko04080	Neuroactive ligand-receptor interaction	2/160	423/7206	0.00603079141449
ko05416	Viral myocarditis	5/160	55/7206	0.00721089013337
ko05212	Pancreatic cancer	6/160	83/7206	0.0100858269
ko05220	Chronic myeloid leukemia	6/160	85/7206	0.0112729034205
ko05418	Fluid shear stress and atherosclerosis	9/160	173/7206	0.0146489122522
ko05120	Epithelial cell signaling in Helicobacter pylori infection	6/160	92/7206	0.0162052900306
ko05200	Pathways in cancer	19/160	492/7206	0.0163408544802
ko04218	Cellular senescence	9/160	177/7206	0.0167840445651
ko04010	MAPK signaling pathway	14/160	321/7206	0.0171836690276
ko04932	Non-alcoholic fatty liver disease (NAFLD)	9/160	182/7206	0.0197638886128
ko05132	Salmonella infection	6/160	98/7206	0.0214814675155
ko05146	Amoebiasis	6/160	99/7206	0.022461548921
ko04664	Fc epsilon RI signaling pathway	5/160	77/7206	0.027820819902
ko04610	Complement and coagulation cascades	5/160	79/7206	0.0306462296544
ko04930	Type II diabetes mellitus	4/160	54/7206	0.0313624767026
ko04137	Mitophagy - animal	5/160	82/7206	0.035212359422
ko05210	Colorectal cancer	5/160	86/7206	0.0419242604147
ko00660	C5-Branched dibasic acid metabolism	1/160	2/7206	0.0439174463881
ko05150	Staphylococcus aureus infection	3/160	36/7206	0.0449503590263